Wiktorowicz J E, Awasthi Y C, Kurosky A, Srivastava S K
Biochem J. 1977 Jul 1;165(1):49-53. doi: 10.1042/bj1650049.
Hexosaminidases (EC 3.2.1.30) A and B from human kidney cortex were purified to homogeneity by using concanavalin A affinity chromatography, ion-exchange chromatography and gel filtration. The yield of homogeneous isoenzymes improved approx. 20-fold, giving preparations of hexosaminidases A and B with specific activities of about 200 and 325 units/mg of protein respectively. The kinetic and structural properties of kidney hexosaminidase isoenzymes were studied and compared with the hexosaminidase isoenzymes from human placenta. The amino acid composition of hexosaminidase A was significantly different from that of hexosaminidase B. In the event of success in developing enzyme-replacement therapy for Tay-Sachs and Sandhoff's diseases, this modified procedure can furnish larger amounts of homogeneous isoenzymes.
通过使用伴刀豆球蛋白A亲和色谱法、离子交换色谱法和凝胶过滤法,将人肾皮质中的己糖胺酶(EC 3.2.1.30)A和B纯化至同质。同质同工酶的产量提高了约20倍,得到的己糖胺酶A和B制剂的比活性分别约为200和325单位/毫克蛋白质。研究了肾己糖胺酶同工酶的动力学和结构特性,并与人胎盘的己糖胺酶同工酶进行了比较。己糖胺酶A的氨基酸组成与己糖胺酶B的显著不同。如果成功开发出针对泰-萨克斯病和桑德霍夫病的酶替代疗法,这种改进的方法可以提供大量的同质同工酶。